Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 10/2008

01.10.2008 | Editorial

How much CT is needed in nuclear medicine

verfasst von: Chirayu Shah, James A. Patton, Martin P. Sandler

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 10/2008

Einloggen, um Zugang zu erhalten

Excerpt

There is a major trend toward reducing the cost of medical care. One of the ways to meet this challenge is to diagnose and treat diseases in their infancy. With the advent of multislice computerized tomography (CT) scans, exquisite anatomical detail is available in shorter time intervals. However, anatomical changes are, by definition, the result of disease process and are thus evident only after the disease has progressed significantly. This has led to a major paradigm shift toward functional and physiologic imaging. We, in nuclear medicine, have the privilege of being able to detect physiological and pathophysiological changes that occur as a result of disease process long before anatomical changes are appreciated. With the emergence of molecular imaging, we are now researching targeted imaging and therapeutic agents that will enable us to visualize these changes at the molecular and cellular levels so as to diagnose diseases in their infancy before they progress or complications arise, resulting in both improved and efficient patient care at reduced cost. …
Metadaten
Titel
How much CT is needed in nuclear medicine
verfasst von
Chirayu Shah
James A. Patton
Martin P. Sandler
Publikationsdatum
01.10.2008
Verlag
Springer-Verlag
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 10/2008
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-008-0843-9

Weitere Artikel der Ausgabe 10/2008

European Journal of Nuclear Medicine and Molecular Imaging 10/2008 Zur Ausgabe